# Genmab A/S: Form 6-K, filed Oct 2, 2026

- Company: [Genmab A/S](/companies/gmab.md) (CIK 1434265)
- Form: 6-K
- Filed: 2026-10-02
- Accepted by EDGAR: Oct 2, 2026, 13:51 ET
- Period: 2026-10-02
- Accession: 0001434265-26-000129
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1434265/000143426526000129/gmab_20261002x6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434265/000143426526000129/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434265/000143426526000129/gmab_20261002x6k.htm

Filed Oct 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001434265-26-000129. Last ingested by Listed: Nov 13, 2026, 10:58 ET. No prices; not investment advice.
